Home
Areas of expertise
Technology
About us
News

December, 2014

Cyprumed receives preseed grant from AWS

Ready to collaborate?

About us

Cyprumed is a dedicated drug delivery company based in Innsbruck, Austria. Our main focus is the development of proprietary technology platforms for the oral administration of therapeutic peptides. In addition, we are active in the field of oral delivery of Biopharmaceutics Classification System injectable (BCS Class IV) drugs.

Navigation

Areas of expertise
Technology
About us
News

Privacy policy

Imprint

Cookie Settings

Home
Areas of expertise
Technology
About us
News

Contact